Fabrice Cerini Selected Research

N(alpha)- (n- nonanoyl)- desSer(1)- (thioproline(2),cyclohexylglycine(3))- RANTES

11/2008

Highly potent, fully recombinant anti-HIV chemokines: reengineering a low-cost microbicide.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fabrice Cerini Research Topics

Disease

2	Inflammation (Inflammations) 01/2021 - 11/2008
2	Neoplasms (Cancer) 01/2021 - 01/2016
2	HIV Infections (HIV Infection) 03/2016 - 02/2008
1	COVID-19 01/2021
1	Chest Pain (Chest Pains) 01/2015
1	Autoimmune Diseases (Autoimmune Disease) 01/2015
1	Unstable Angina 01/2015
1	ST Elevation Myocardial Infarction 01/2015
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2015
1	Acquired Immunodeficiency Syndrome (AIDS) 12/2008

Drug/Important Bio-Agent (IBA)

2	Proteins (Proteins, Gene)FDA Link 01/2016 - 01/2015
1	CCR5 Receptors (CCR5 Receptor)IBA 01/2021
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2021
1	AIDS VaccinesIBA 03/2016
1	Cell-Penetrating PeptidesIBA 01/2016
1	EpitopesIBA 01/2016
1	Cancer VaccinesIBA 01/2016
1	Peptides (Polypeptides)IBA 01/2015
1	AutoantibodiesIBA 01/2015
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2015
1	VaccinesIBA 12/2008
1	Anti-Infective Agents (Microbicides)IBA 12/2008
1	N(alpha)- (n- nonanoyl)- desSer(1)- (thioproline(2),cyclohexylglycine(3))- RANTESIBA 11/2008

Therapy/Procedure

2	Therapeutics 01/2015 - 02/2008